Contributors
HERVE ´ ACLOQUE • Inserm, UMRS935 ESTeam Paris Sud, Malignant and Therapeutic Stem
Cell Models, Villejuif, France; GABI, INRA, AgroParisTech, Universite ´ Paris-Saclay,
Jouy-en-Josas, France
JAMIE ADAMS • Department of Biomedical Science and Bateson Centre, The University of
Sheffield, Sheffield, UK
ZAIN ALHASHEM • Randall Centre for Cell and Molecular Biophysics, King’s College,
London, UK
GUILLAUME ALLIO • Centre de Biologie du De ´veloppement (CBD), Centre de Biologie Inte ´
grative (CBI), Universite ´ de Toulouse, CNRS, UPS, Toulouse, France
BERTRAND BE ´ NAZE ´ RAF • Centre de Biologie du De ´veloppement (CBD), Centre de Biologie Inte ´
grative (CBI), Universite ´ de Toulouse, CNRS, UPS, Toulouse, France
ANNELISE BENNACEUR-GRISCELLI • Inserm, UMRS935 ESTeam Paris Sud, Malignant and
Therapeutic Stem Cell Models, Villejuif, France; Service d’he ´matologie, APHP, GHU Paris
Sud, Villejuif, France; University Paris Sud, University Paris-Saclay, UFR de Me ´decine
Kremlin Bice ˆtre, Le Kremlin-Bice ˆtre, France
ALEJANDRO BERRIO • Department of Biology, Duke University, Durham, NC, USA
SUGANDHA BHATIA • Faculty of Health, Institute of Health and Biomedical Innovation and
School of Biomedical Sciences, Queensland University of Technology, Brisbane, QLD,
Australia; Translational Research Institute, Brisbane, QLD, Australia
NICOLAS BORGHI • Institut Jacques Monod, Universite ´ de Paris, CNRS, Paris, France
MINERVA BOSCH-FORTEA • Program of Tissue and Organ Homeostasis, Centro de Biologı ´a
Molecular Severo Ochoa (CSIC-UAM), Madrid, Spain; Institute of Bioengineering and
School of Engineering and Materials Science, Queen Mary University of London, London,
UK
MARIANNE E. BRONNER • Department of Biology and Biological Engineering, California
Institute of Technology, Pasadena, CA, USA
NATALIA A. BULGAKOVA • Department of Biomedical Science and Bateson Centre, The
University of Sheffield, Sheffield, UK
KERSTIN BYSTRICKY • Center for Integrative Biology (CBI), Laboratoire de Biologie Mole ´
culaire des Eucaryotes (LBME), University of Toulouse, UPS, CNRS, Toulouse, France
KYRA CAMPBELL • Department of Biomedical Science and Bateson Centre, The University of
Sheffield, Sheffield, UK
HELENA CANEVER • Institut Jacques Monod, Universite ´ de Paris, CNRS, Paris, France
SYLVAIN CANTALOUBE • Center for Integrative Biology (CBI), Laboratoire de Biologie Mole ´
culaire des Eucaryotes (LBME), University of Toulouse, UPS, CNRS, Toulouse, France
PIETRO SALVATORE CAROLLO • Institut Jacques Monod, Universite ´ de Paris, CNRS, Paris,
France
ANDREU CASALI • Serra Hu ´ nter fellow, Department of Basic Medical Sciences, Institut de
Recerca Biome `dica de Lleida (IRBLleida), University of Lleida, Lleida, Spain
SEFORA CONTI • Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute
for Science and Technology (BIST), Barcelona, Spain
CECILE DAVAINE • Inserm, UMRS935 ESTeam Paris Sud, Malignant and Therapeutic Stem
Cell Models, Villejuif, France
xi
HERVE ´ ACLOQUE • Inserm, UMRS935 ESTeam Paris Sud, Malignant and Therapeutic Stem
Cell Models, Villejuif, France; GABI, INRA, AgroParisTech, Universite ´ Paris-Saclay,
Jouy-en-Josas, France
JAMIE ADAMS • Department of Biomedical Science and Bateson Centre, The University of
Sheffield, Sheffield, UK
ZAIN ALHASHEM • Randall Centre for Cell and Molecular Biophysics, King’s College,
London, UK
GUILLAUME ALLIO • Centre de Biologie du De ´veloppement (CBD), Centre de Biologie Inte ´
grative (CBI), Universite ´ de Toulouse, CNRS, UPS, Toulouse, France
BERTRAND BE ´ NAZE ´ RAF • Centre de Biologie du De ´veloppement (CBD), Centre de Biologie Inte ´
grative (CBI), Universite ´ de Toulouse, CNRS, UPS, Toulouse, France
ANNELISE BENNACEUR-GRISCELLI • Inserm, UMRS935 ESTeam Paris Sud, Malignant and
Therapeutic Stem Cell Models, Villejuif, France; Service d’he ´matologie, APHP, GHU Paris
Sud, Villejuif, France; University Paris Sud, University Paris-Saclay, UFR de Me ´decine
Kremlin Bice ˆtre, Le Kremlin-Bice ˆtre, France
ALEJANDRO BERRIO • Department of Biology, Duke University, Durham, NC, USA
SUGANDHA BHATIA • Faculty of Health, Institute of Health and Biomedical Innovation and
School of Biomedical Sciences, Queensland University of Technology, Brisbane, QLD,
Australia; Translational Research Institute, Brisbane, QLD, Australia
NICOLAS BORGHI • Institut Jacques Monod, Universite ´ de Paris, CNRS, Paris, France
MINERVA BOSCH-FORTEA • Program of Tissue and Organ Homeostasis, Centro de Biologı ´a
Molecular Severo Ochoa (CSIC-UAM), Madrid, Spain; Institute of Bioengineering and
School of Engineering and Materials Science, Queen Mary University of London, London,
UK
MARIANNE E. BRONNER • Department of Biology and Biological Engineering, California
Institute of Technology, Pasadena, CA, USA
NATALIA A. BULGAKOVA • Department of Biomedical Science and Bateson Centre, The
University of Sheffield, Sheffield, UK
KERSTIN BYSTRICKY • Center for Integrative Biology (CBI), Laboratoire de Biologie Mole ´
culaire des Eucaryotes (LBME), University of Toulouse, UPS, CNRS, Toulouse, France
KYRA CAMPBELL • Department of Biomedical Science and Bateson Centre, The University of
Sheffield, Sheffield, UK
HELENA CANEVER • Institut Jacques Monod, Universite ´ de Paris, CNRS, Paris, France
SYLVAIN CANTALOUBE • Center for Integrative Biology (CBI), Laboratoire de Biologie Mole ´
culaire des Eucaryotes (LBME), University of Toulouse, UPS, CNRS, Toulouse, France
PIETRO SALVATORE CAROLLO • Institut Jacques Monod, Universite ´ de Paris, CNRS, Paris,
France
ANDREU CASALI • Serra Hu ´ nter fellow, Department of Basic Medical Sciences, Institut de
Recerca Biome `dica de Lleida (IRBLleida), University of Lleida, Lleida, Spain
SEFORA CONTI • Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute
for Science and Technology (BIST), Barcelona, Spain
CECILE DAVAINE • Inserm, UMRS935 ESTeam Paris Sud, Malignant and Therapeutic Stem
Cell Models, Villejuif, France
xi